Iszo Capital Management LP / PTGX
Iszo Capital Management LP’s Protagonist Therapeutics Inc Position
Does Iszo Capital Management LP own Protagonist Therapeutics Inc (PTGX)? Not currently — the last reported position was 93.9K shares worth $4M in Q2 2021; the fund’s latest 13F (Q4 2023) no longer reports it.
Position Value
$4M
Q2 2021
Shares
93.9K
% of Portfolio
+1.53%
Quarters Held
1
position exited
Position History PTGX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2021 | 93.9K | $4M | +1.53% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Iszo Capital Management LP’s full portfolio or all institutional holders of PTGX.